How Psychiatry Journals Support the Unbiased Translation of Clinical Research. A Cross-Sectional Study of Editorial Policies

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Knüppel, Hannes ^a   Metz, Courtney ^a,b   Meerpohl, Joerg J ^c   Strech, Daniel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROLLED STUDY; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL SERVICE; MEDICAL SOCIETY; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; POLICY; PRACTICE GUIDELINE; PSYCHIATRY; PUBLICATION; PUBLISHING; QUALITY CONTROL; REGISTRATION;

AUTHORSHIP; CLINICAL TRIALS AS TOPIC; EDITORIAL POLICIES; HUMANS; JOURNAL IMPACT FACTOR; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRY; PUBLICATION BIAS; PUBLISHING; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84885829959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075995     Document Type: Article

References (36)

1. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, et al. (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. The CONSORT Group. Ann Intern Med 134: 663-694.
2. Juni P, Altman DG, Egger M, (2001) Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 323: 42-46.
3. Schulz KF, Chalmers I, Hayes RJ, Altman DG, (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273: 408-412.
4. Dans AL, Dans LF, Guyatt GH, Richardson S, (1998) Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. JAMA 279: 545-549.
5. Laupacis A, Sackett DL, Roberts RS, (1988) An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 318: 1728-1733.
6. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B, (2003) Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 326: 1171-1173.
7. McHenry L, (2006) Ethical issues in psychopharmacology. J Med Ethics 32: 405-410.
8. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, et al. (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363: 1341-1345.
9. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R, (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358: 252-260.
10. Moher D, Weeks L, Ocampo M, Seely D, Sampson M, et al. (2011) Describing reporting guidelines for health research: a systematic review. J Clin Epidemiol 64: 718-742.
11. Moher D, Jones A, Lepage L, (2001) Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 285: 1992-1995.
12. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, et al. (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340: c869.
13. Brody H, (2012) From an ethics of rationing to an ethics of waste avoidance. The New England Journal of Medicine 366: 1949-1951.
14. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147: 573-577.
15. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
16. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
17. Strech D, Soltmann B, Weikert B, Bauer M, Pfennig A, (2011) Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review. The Journal of clinical psychiatry 72: 1214-1221.
18. Soltmann B, Pfennig A, Weikert B, Bauer M, Strech D, (2012) [Quality of reporting in studies on bipolar disorders: implications for the development of guidelines]. Nervenarzt 83: 604-617.
19. Thornley B, Adams C, (1998) Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 317: 1181-1184.
20. Cipriani A, Malvini L, Furukawa TA, Barbui C, (2007) Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression analysis. J Clin Psychopharmacol 27: 352-356.
21. Han C, Kwak KP, Marks DM, Pae CU, Wu LT, et al. (2009) The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials 30: 116-122.
22. Dickersin K, (1997) How important is publication bias? A synthesis of available data. AIDS Educ Prev 9: 15-21.
23. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG, (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291: 2457-2465.
24. Rising K, Bacchetti P, Bero L (2008) Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med 5: e217; discussion e217.
25. Levin LA, Palmer JG, (2007) Institutional review boards should require clinical trial registration. Arch Intern Med 167: 1576-1580.
26. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, et al. (2004) Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med 141: 477-478.
27. Dickersin K, Rennie D, (2003) Registering clinical trials. JAMA 290: 516-523.
28. ICMJE (2008) Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. International Committee of Medical Journal Editors.
29. Altman DG, (2005) Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ 330: 1056-1057.
30. Hopewell S, Altman DG, Moher D, Schulz KF, (2008) Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials 9: 20.
31. Kunath F, Grobe HR, Rucker G, Engehausen D, Antes G, et al. (2012) Do journals publishing in the field of urology endorse reporting guidelines? A survey of author instructions. Urologia internationalis 88: 54-59.
32. Meerpohl JJ, Wolff RF, Niemeyer CM, Antes G, von Elm E, (2010) Editorial policies of pediatric journals: survey of instructions for authors. Archives of pediatrics & adolescent medicine 164: 268-272.
33. Meerpohl JJ, Wolff RF, Antes G, von Elm E, (2011) Are pediatric Open Access journals promoting good publication practice? An analysis of author instructions. BMC Pediatr 11: 27.
34. Kunath F, Grobe HR, Keck B, Rucker G, Wullich B, et al. (2011) Do urology journals enforce trial registration? A cross-sectional study of published trials. BMJ open 1: e000430.
35. Demicheli V, Di Pietrantonj C (2007) Peer review for improving the quality of grant applications. Cochrane Database Syst Rev: MR000003.
36. Strech D, (2012) Normative arguments and new solutions for the unbiased registration and publication of clinical trials. Journal of Clinical Epidemiology 65: 276-281.